Long-term results of intravesical bacillus calmette-guérin therapy for stage T1 superficial bladder cancer
- 1 May 2000
- Vol. 55 (5) , 673-678
- https://doi.org/10.1016/s0090-4295(99)00591-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladderUrology, 1999
- THE INFLUENCE OF THE LEVEL OF LAMINA PROPRIA INVASION AND THE PREVALENCE OF P53 NUCLEAR ACCUMULATION ON SURVIVAL IN STAGE T1 TRANSITIONAL CELL BLADDER CANCERJournal of Urology, 1998
- Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladderUrology, 1996
- Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1995
- The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancerInternational Urology and Nephrology, 1991
- Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycinUrology, 1990
- The pT1 G3 Bladder TumourBritish Journal of Urology, 1989
- Analysis of the performance of pathologists in the grading of bladder tumorsHuman Pathology, 1983
- Ta and T1 Bladder Cancer: Location, Recurrence and Progression†British Journal of Urology, 1982
- Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladderJournal of Surgical Oncology, 1977